Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-29 @ 11:03 AM
Study NCT ID:
NCT04925934
Status:
COMPLETED
Last Update Posted:
2024-07-23
First Post:
2021-05-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of VIB7734 for the Treatment of Moderate to Severely Active SLE
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-04
First Submit QC Date:
None
Study First Post Date:
2021-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-07
Results First Submit QC Date:
None
Results First Post Date:
2024-07-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-07-23
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-07-21
Last Update Post Date:
2024-07-23
Last Update Post Date Type:
ACTUAL